A rapid and accurate diagnosis of venous thromboembolism (VTE) in the elderly individuals represents a dilemma due to nonspecific clinical presentation, confusing laboratory results, and the hazards of radiological examination in this age-group. D-Dimer test is used mainly in combination with non-high clinical pretest probability (PTP) to exclude VTE. D-Dimer testing retains its sensitivity, however, its specificity decreases in the elderly individuals. Raising the cutoff level improves the specificity of the D-dimer test without compromising its sensitivity. The current study aimed to explore the reliability of higher D-dimer cutoff values for the diagnosis of asymptomatic VTE in a population of bedridden hospitalized elderly patients with non-high clinical PTP. This retrospective study included 252 bedridden hospitalized elderly patients (>65 years) who were admitted to the Ain shams University Specialized Hospital with non-high clinical probability and developed later reduced mobility; all underwent quantitation of D-dimer and Doppler examination. Considering the whole population (>65 years), the age-adjusted cutoff achieved the best performance in comparison with the conventional and receiver operating characteristic (ROC)-derived cutoffs. When stratified according to age, the age-adjusted cutoff showed the best performance in the age-group 65-70 and comparable performance with the ROC-derived cutoff in the age-group 71-80, however, its sensitivity compromised in those older than 80 years. In conclusion, it is recommended to use age-adjusted cutoff value of D-dimer together with the clinical probability score in elderly individuals (65-80 years).
Introduction
Deep vein thrombosis (DVT) and its possible life-threatening consequence, pulmonary embolism (PE), are leading causes of preventable morbidity and mortality following the hospitalization of elderly people. 1 Accurate and timely diagnosis of venous thromboembolism (VTE) can be lifesaving especially in this age-group due to short-term mortality. 2 However, in bedridden elderly patients, the diagnosis of DVT may be challenging because of the high prevalence of asymptomatic cases. 3, 4 Nowadays, the diagnostic workup for suspected VTE has evolved into an integrated approach that includes pretest probability (PTP) assessment and D-dimer testing in combination with imaging. 5, 6 D-Dimer assay is the best recognized biomarker for the initial assessment of suspected VTE due to high sensitivity in comparison with poor specificity; false-positive D-dimer results have been noted in inflammation, pregnancy, malignancy, and the elderly individuals. 7 A high proportion of elderly patients with a non-high clinical probability undergo unnecessary burdensome diagnostic investigations, in whom the yield of this imaging is relatively low. Hence, D-dimer tests are often used to rule out VTE (PE or DVT) in these patients in contrast to those with a high clinical probability in whom imaging examination is warranted to confirm or refute the diagnosis irrespective of the D-dimer results. 8 D-Dimer levels significantly increase with age possibly due to a higher incidence of comorbidity. Although the incidence of VTE increases with age, the proportion of the patients with a D-dimer level lower than the conventional cutoff value (500 mg/mL for the most available commercial assays) and in whom the diagnosis of VTE may be ruled out by the test is reduced. 9 Recently, many studies evaluated different approaches to improve the specificity of D-dimer test in the elderly individuals, using either different cutoff values in the elderly population, in combination with the PTP score, or adopting different age-dependent cutoff values for patients older than 50 years (patient's age Â 10 mg/L fibrinogen equivalent units [FEU] ). Many studies were proposed on the basis of retrospective studies regarding patients with suspected DVT or PE, 8, [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] The aim of our study was to assess different D-dimer cutoffs combined with clinical PTP for better specificity of the D-dimer without compromising sensitivity, that is, safer exclusion of VTE.
Participants and Methods
This study was an observational retrospective study that was conducted from June 2013 till January 2014 in the Ain Shams University Specialized Hospital. All patients in our study were subjected to the following:
Inclusion Criteria
1. Clinical assessment: for exclusion of any VTE signs and symptoms using the Wells scoring system, selecting those with non-high clinical probability. 2. Laboratory assessment: quantitative determination of D-dimer using the INNOVANCE D-dimer assay, an automated, particle-enhanced, immunoturbidimetric assay for the cross-linked fibrin degradation products (D-dimers) in human plasma on Sysmex CA-1500 (Siemens Diagnostics, Germany). The results were expressed in mg/L FEU. Two milliliters of venous blood were collected from the patients on a trisodium citrate vacutainer (1 part of citrated sodium [0.109 mmol/L] with 9 parts of venous blood). Platelet-poor plasma was obtained by centrifugation at 3000g in room temperature, aliquoted, snap frozen, and stored at À70 C for further analysis; hemolysed samples were discarded.
3. Radiological assessment: Doppler examination of both lower limbs by a general electric logiq 9 device performed with a real-time, B mode, linear-array sonographic scanner at 5.0 to 7.5 MHz. The entire proximal deep vein system was explored for compressibility.
Study Design
Patients were analyzed by 2 approaches: whole population (!65 years) and age-stratified groups-first group 65 to 70 years, second group 71 to 80 years, and third group above 80 years.
The following cutoff values were applied:
The ''conventional'' cutoff value for INNOVANCE Ddimer provided by the manufacturer was 0.5 mg/L FEU irrespective of the patient's age. The receiver operating characteristic (ROC)-derived cutoff value showing the best specificity, while preserving the 100% sensitivity. An ''age-adjusted'' cutoff (age in years Â 10 mg/L) proposed by Douma et al. 21, 22 On correlating the results of both Doppler ultrasound examination and D-dimer regarding the 3 cutoff values, patients were stratified into true-positive, true-negative, false-positive, and false-negative cases, and the following were calculated for each cutoff level: Sensitivity, specificity, positive predictive value, negative predictive value, and accuracy. The proportion in which DVT could be excluded (based on an unlikely clinical probability and a negative Ddimer test result using the different cutoff values), that is, true negatives. The number of patients needed to undergo a D-dimer assay to exclude DVT in 1 patient (ie, the number of patients needed to test by dividing 1 by the proportion of true negatives).
Statistical Analysis
Data were analyzed using Statistical Package for the Social Science (SPSS; version 15), a statistical software package for the Windows XP operating system of IBM-compatible personal computer. The w 2 test was used for comparison of qualitative data. Student t test was used for comparison of quantitative data. Receiver operating characteristic curves were prepared, and for each cutoff value, the area under the curve and the 95% confidence interval (CI) were calculated. We used the Wilson score method to compute the 95% CI for estimated proportions.
Results
Of a total 1123 patients older than 65 years who were admitted to the emergency department of Ain Shams University Specialized Hospital, 252 were serially included according to our inclusion and exclusion criteria (non-high PTP of VTE). Four hundred eight patients were not admitted to the hospital and left after the emergency department visit, 117 patients either refused our study or dropped out before completion of the desired tests, 100 patients were already on anticoagulation, 23 patients died after admission within 48 hours, 192 didn't report any reduced mobility, 4 patients had previous recurrent DVT, 25 patients were presenting with signs and symptoms suggestive of DVT, and 2 patients' radiological assessment wasn't successful.
There were 127 (50.3%) males and 125 (49.6%) females with a male to female ratio of 1.01:1. Their ages ranged from 65 to 98 years with a mean of 73.3 years and standard deviation (SD) ¼ 6.74. Frequency of different age-groups among our sample is shown in Table 1 .
They were divided according to the cause of admission with infection as the main cause of admission, representing 23.8% of the total sample. Pearson w 2 test was performed to determine the association between the cause of admission, presence and number of comorbidities, and the appearance of positive radiological findings. There was no statistically significant correlation between the medical grounds for admission and the prevalence of DVT ( Table 2) .
Laboratory and radiological results were collected from the patients' charts in Ain Shams University Hospitals.
D-Dimer Results
D-Dimer test performed on the participants showed values with a mean of 1.23, SD of 1.065, range of 0.06 up to 6.9 mg/L, and mode of 0.9 mg/L, with a mean value of males (1.24, SD 0.96) being higher than the mean value of females (1.17, SD 1.07).
For patients ages 65 to 70 years, D-dimer had a mean of 1.24, SD of 1.08 mg/L, and mode of 1.5 mg/L. However, for patients aged 71 to 80 years, D-dimer had a mean of 1.32, SD of 1.04 mg/L, and mode of 0.8 mg/L. D-Dimer in patients with ages 80 and above had a mean of 0.97, SD of 1.00 mg/L, and mode of 0.9 mg/L.
Radiological Data
Ninety (35.7%) of our participants showed compression changes in their lower limb by duplex sonography, diagnosed as having DVT with prevalence of 35.7% in the non-high PTP, whereas 162 (64.3%) showed normal patency and compressibility of blood vessels and normal blood flow inside it (proved to be free from DVT).
Patients who were found to have DVT by radiological examination had D-dimer results with a mean 1.98 + 1.19 mg/L. Patients without DVT had D-dimer results with a mean 0.81 + 0.69 mg/L. Table 3 shows that the best performance was for the ageadjusted cutoff in comparison with the conventional and ROC-derived cutoffs in the whole population. Table 4 shows that the age-adjusted cutoff achieved the best performance in the 65 to 70 age-group and with comparable performance to the ROC-derived cutoff in the 71 to 80 agegroup, however, its sensitivity compromised in those older than 80 years in whom the conventional and ROC-derived cutoffs show comparable performance.
Study of the Whole Sample Population

Study of Age-Specific Groups Revealed the Following Results
The pooled specificity of D-dimer testing decreased substantially with increasing age from 37.3% in patients aged 65 to 70 years to 25% in patients aged 71 to 80 years and increased to 52.6% in those >80 years when the conventional cutoff value was applied, whereas the pooled sensitivity hardly differed between the age-groups ( Table 4 ).
The prevalence of DVT was comparable between groups, 36.3% (65-70 years), 37.9% (71-80 years), and 31.8% (>80 years), with the overall prevalence in the whole population being 35.7%
Discussion
In elderly patients, specificity of D-dimer is compromised owing to the raised D-dimer levels without any underlying thrombotic disease, which increases the false-positive results and hence raises the number of patients undergoing unnecessary radiological examination. Developing more accurate interpretation of D-dimer results will reduce the financial burden of unnecessary tests and ensure not missing the diagnosis, which may be fatal.
Using the conventional cutoff for D-dimer (0.5 mg/L) that is suggested by most manufacturers and has been adopted by many institutions, laboratory, and clinicians worldwide will lead to a high number of false-positive results in elderly patients. An obvious solution to this problem was raising the cutoff to a level that improves the specificity of D-dimer test without compromising its sensitivity.
The aim of the current study was to explore the reliability of 3 different D-dimer cutoff values: the conventional cutoff (0.5 mg/L), the ROC-derived cutoff value, showing the best specificity while preserving the 100% sensitivity, and the age-adjusted cutoff (age in years Â 10 mg/L) proposed by Douma et al 21, 22 for the diagnosis of asymptomatic VTE in a population of bedridden hospitalized elderly patients in whom the clinical presentation per se wasn't decisive. The current study was carried out on 252 bedridden hospitalized elderly patients with non-high PTP for VTE based on clinical decision rules applying Wells' scoring system ( 2), with exclusion criteria, inclusion criteria, and study design similar to the studies by Granziera et al, 23 Cini et al, 24 Douma et al, 22 Harper et al, 9 and Schouten et al 8 as this is the indicated population for the application of D-dimer tests as opposed to the studies by Lippi et al, 25 Haas et al, 10 Han et al, 26 and Schouten et al 27 who included patients with high PTP for VTE. All patients in our study were subjected to clinical assessment, D-dimer testing, and Doppler examination. D-Dimer testing in the present study was performed by INNOVANCE D-dimer assay using a CA-1500 Sysmex Siemens analyzer. Other studies [8] [9] [10] [22] [23] [24] 26 assessed different assays on different analyzers: Tinaquant Roche, rapid ELISA Vidas D-dimer bioMérieux, and STA-Liatest D-dimer test, with 23 had a study population of 199 patients with mean age of 86.3 + 6.7 years, showing 29.1% of patients were admitted due to infection and 12.5% due to the prevalence of DVT, and neither studies showed correlation between any medical grounds for admission and the prevalence of DVT. D-Dimer values in the present study had a mean of 1.23 + 1.065 mg/L that is close to the mean of D-dimer values reported by Granziera et al, 23 which was 1.2 + 1.5 mg/L. Other studies didn't report mean values of D-dimer.
Studying the Sample Population as a Whole
Performance of the conventional D-dimer cutoff value of 0.5 mg/L in the present study was close to the results obtained by similar studies [8] [9] [10] [23] [24] 26 characterized by compromised specificity, while keeping the sensitivity above 97%.
The best performance was for the age-adjusted cutoff, showing the highest specificity of 52.4%, accuracy of 68.6%, percentage safely excluded of 33.7% with an absolute increase of 9.1% and 6.7%, and the least number of patients needed to be tested to exclude DVT in 1 patient (2.96) in comparison with the conventional cutoff and the ROC-derived cutoff (0.6 mg/L), respectively, while keeping the sensitivity at 97.8% due to the loss of 2 cases (2 false negatives) in those older than 80 years.
Similar to Han et al 26 who reported age-adjusted cutoff formula to give sensitivity of 95% and specificity of 84.1% for his non-high (low and moderate) PTP population, Cini et al 24 reported the age-adjusted cutoff formula to give sensitivity of 100% and specificity of 67.3% with an absolute increase in percentage safely excluded (24.1%) and reduced number needed to test from 2.8 to 1.7 for his whole population and Schouten et al 8 documented increased specificity from 42% to 47.8% and a decrease in the number of cases needed to test from 2.4 to 2.1 with an absolute increase in percentage of excluded cases (efficiency; 5.7%) when applied the ageadjusted cutoff formula.
In this study, the ROC-derived cutoff value showing the best specificity while preserving the 100% sensitivity was at 0.6 mg/L and gave specificity of 42%, which is lower than that reported by Haas et al 10 who suggested a cutoff value of 0.75 mg/L, which gives a sensitivity of 100% and a specificity of 49.2%. Harper et al 9 chose a point of 1.00 mg/L, improving the specificity to 55% and reported sensitivity of >98%, Granziera et al 23 suggested raising the cutoff value to 0.49 DDU mg/L (equivalent to 0.98 mg/L FEU), which increased the specificity from 20.1% to 39.1% while keeping the sensitivity as 100%, and Cini et al 24 suggested raising the cutoff value to 376 DDU ng/mL (equivalent to 752 ng/mL FEU), which increased specificity to 63.7% while keeping sensitivity as 100%, and the fixed cutoff (>750) adopted by Schouten et al 8 with specificity being improved from 42% to 47.4%.
Stratifying the Sample Population According to Age
Studying those aged 65 to 70 years. In the present study, performance of the conventional cutoff (0.5 mg/L) showed sensitivity above 99% and compromised specificity, which was close to other studies done on the similar age-group. 8, 24, 27 The best performance in this age-group was for the ageadjusted cutoff showing the highest specificity of 50.46%, accuracy of 68.4%, and proportion of safely excluded patients of 32.1% with an absolute increase of 8.3% and 5.9% in comparison with the conventional cutoff and the ROC-derived cutoff (0.6 mg/L), respectively, while preserving 100% sensitivity with the least number of patients needed to be tested to exclude DVT in 1 patient (3.1). This is very close to the results obtained by Schouten et al 27 who showed 97.3% sensitivity and 49.5% specificity, Schouten et al 8 who reported 98.5% sensitivity, 39.3% specificity, and number of cases needed to test 2.6, efficiency 6.5% for the similar age-group of 61 to 70 years, and Cini et al 24 who documented 100% sensitivity, 71.9% specificity, and number of cases needed to test 1.4. The number of cases excluded increased to 24.5% when applied the ageadjusted cutoff formula.
Analysis of the ROC curve revealed that the cutoff value showed the best specificity of 41.1%, while preserving 100% sensitivity at 0.6 mg/L with accuracy of 62.5%, percentage safely excluded of 26.2%, number needed to test as 3.8 in comparison with the study reported by Schouten et al 8 who adopted a fixed cutoff (>750 ng/mL) with a sensitivity of 98.5%, a specificity of 42.1%, number of cases needed to test as 2.4, and efficiency as 9.3% and the study by Cini et al 24 using the modified cutoff (376 ng/mL DDU) with 100% sensitivity for this age-group, 73.7% specificity number of cases needed to test to be 1.4, and the number of cases excluded increased to 26.3%.
Studying those aged 71 to 80 years. Both the ROC-derived cutoff (0.8 mg/L) and the age-adjusted cutoff values showed comparable specificities (55.5% and 52.7%, respectively), accuracies (72.4% and 70.7%), and proportions of safely excluded patients (34.5% and 32.7%), which are higher than those of the conventional cutoff specificity (25%), accuracy (53.4%), and proportion of safely excluded patients (15.5%) with an absolute increase of 17.5% using the age-adjusted cutoff and 19% using 0.8 mg/L cutoff than using conventional cutoff, while preserving 100% sensitivity with the least number of patients needed to be tested to exclude DVT in 1 patient, 2.9 and 3.1, respectively, versus 6.45 for the conventional cutoff.
In accordance with the study by Schouten et al, 8 comparable performance of both age-adjusted cutoff and their fixed cutoff for this age-group showed 100% sensitivity, 45% specificity, number of cases needed to test to be 2.2, and 14.4% efficiency for the former and 100% sensitivity, 45.9% specificity, number of cases needed to test to be 2.2, and 15.3% efficiency for the latter. Similarly, Cini et al 24 reported comparable performance of both age-adjusted cutoff and their modified cutoff with 100% sensitivity, 50% specificity, number of cases needed to test to be 2.0, and proportion of cases excluded increased to 29.3% for the former and 100% sensitivity, 48.8% specificity, number of cases needed to test to be 2.0, and proportion of cases excluded increased to 28.1% for the latter.
Also in a close proximity to Schouten et al, 27 results showed 97.3% sensitivity and 44.2% specificity for the age-adjusted formula.
Studying those aged 81 years and above. Both the ROC-derived cutoff (0.550 mg/L) and the conventional cutoff values showed comparable specificities (57.9% and 52.6%, respectively), accuracy (69.2% and 65.4%%), proportions of safely excluded patients (42.3% and 38.5%), and number of cases needed to test (2.36 and 2.6), while preserving 100% sensitivity. The ageadjusted cutoff did show an increase in specificity (63.16%) however at the expense of sensitivity (71.4%), making the ageadjusted formula not suitable to replace conventional cutoff (0.5 mg/L).
Similar studies 8, 24, 27 showed the age-adjusted cutoff to have the best performance in this age-group. However, our findings should be cautiously interpreted due to the small number of patients >80 years (n ¼ 26) in comparison with the large cohort of patients in the study by Schouten et al 27 In conclusion, in bedridden hospitalized elderly patients (65-80 years), combining the clinical probability for VTE with an age-adjusted formula 21 for the interpretation of D-dimer results improves the clinical utility of D-dimer with safer exclusion of DVT. However, further prospective impact studies are needed before application in daily clinical practice.
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